LESLEY METTS: Open Payments
NPI 1205509726 · KNOX, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 34 payments from 14 companies in 2025. Trend: 2023 $543 · 2024 $514 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $231 |
| Lilly USA, LLC | 3 | $64 |
| Verona Pharma, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Almatica Pharma LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: REXULTI, MOUNJARO, Ohtuvayre, CAPLYTA, Auvelity, VRAYLAR, LOREEV XR, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
